Free Trial

Arcadia Biosciences Q4 2022 Earnings Report

Arcadia Biosciences logo
$3.98 -0.41 (-9.34%)
As of 02/21/2025 03:59 PM Eastern

Arcadia Biosciences EPS Results

Actual EPS
-$6.31
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Arcadia Biosciences Revenue Results

Actual Revenue
$1.00 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Arcadia Biosciences Announcement Details

Quarter
Q4 2022
Time
N/A

Conference Call Resources

Arcadia Biosciences Earnings Headlines

Arcadia Biosciences (NASDAQ:RKDA) Now Covered by StockNews.com
$5,000 DOGE check?
Elon Musk's DOGE agenda just took a very surprising turn... Earlier this week, reports emerged that a portion of the savings DOGE makes in Federal cuts could be funneled back to taxpayers. The media was quick to dub it a DOGE Dividend, with claims circulating that we could all receive a $5,000 check in the mail.
Arcadia Biosciences (RKDA) Gets a Buy from Lake Street
See More Arcadia Biosciences Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Arcadia Biosciences? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Arcadia Biosciences and other key companies, straight to your email.

About Arcadia Biosciences

Arcadia Biosciences (NASDAQ:RKDA) produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring. The company was incorporated in 2002 and is headquartered in Dallas, Texas.

View Arcadia Biosciences Profile

More Earnings Resources from MarketBeat